» Articles » PMID: 22971485

Intact Versus Fragmented 99mTc-monoclonal Antibody Imaging of Infection in Patients with Septically Loosened Total Knee Arthroplasty

Overview
Journal J Int Med Res
Publisher Sage Publications
Specialty General Medicine
Date 2012 Sep 14
PMID 22971485
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: This prospective study compared the diagnostic accuracy of imaging using an intact murine antigranulocyte antibody 99mTc-besilesomab, and a murine antibody Fab fragment 99mTc-sulesomab, in patients with suspected septically loosened total knee arthroplasty.

Methods: Images from 20 patients who underwent threephase bone scintigraphy followed by imaging using 99mTc-besilesomab (n=10) or 99mTc-sulesomab (n=10) were evaluated and compared. Final diagnosis was determined by microbiological evaluation of aspirated synovial fluid, intraoperative samples through the clinical course, or by long-term follow-up.

Results: Prosthesis infection was shown in 18 patients. At 4 and 24 h after intravenous injection, absolute uptake of 99mTc-besilesomab was significantly higher than 99mTc-sulesomab in infected knee joints. Infected-to-healthy knee activity ratios were similar at 4 and 24 h for 99mTc-besilesomab and 99mTc-sulesomab.

Conclusions: Both 99mTc-besilesomab and 99mTc-sulesomab had similar diagnostic accuracy for the detection of septic arthroplasty. If repeated use of immunoscintigraphy is needed for follow-up, 99mTc-sulesomab should be preferred over 99mTc-besilesomab since it is known to be well tolerated and without side effects or incompatibility reactions.

Citing Articles

Semi-quantitative analysis with Tc-Besilesomab in musculoskeletal system infections.

Guardia-Jimena P, Martinez-Valle Torres M, Arenas Aguaza R, Gonzalez Ramirez A, Becerra-Garcia D, Guirado D Bone Rep. 2023; 19:101708.

PMID: 37664143 PMC: 10474153. DOI: 10.1016/j.bonr.2023.101708.


The Role of Imaging Techniques to Define a Peri-Prosthetic Hip and Knee Joint Infection: Multidisciplinary Consensus Statements.

Romano C, Petrosillo N, Argento G, Sconfienza L, Treglia G, Alavi A J Clin Med. 2020; 9(8).

PMID: 32781651 PMC: 7466174. DOI: 10.3390/jcm9082548.


Technetium-99m (⁹⁹mTc)-labelled sulesomab in the management of malignant external otitis: is there any role?.

Galletti F, Cammaroto G, Galletti B, Quartuccio N, Di Mauro F, Baldari S Eur Arch Otorhinolaryngol. 2014; 272(6):1377-82.

PMID: 24534898 DOI: 10.1007/s00405-014-2938-1.


Use of anti-granulocyte scintigraphy with 99mTc-labeled monoclonal antibodies for the diagnosis of periprosthetic infection in patients after total joint arthroplasty: a diagnostic meta-analysis.

Xing D, Ma X, Ma J, Wang J, Chen Y, Yang Y PLoS One. 2013; 8(7):e69857.

PMID: 23922825 PMC: 3724677. DOI: 10.1371/journal.pone.0069857.